Augmentation of dopaminergic agents for major depressive disorder
- PMID: 19317962
- DOI: 10.4088/JCP.08lr04686
Augmentation of dopaminergic agents for major depressive disorder
Comment on
-
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial.J Clin Psychiatry. 2008 Jan;69(1):87-94. doi: 10.4088/jcp.v69n0112. J Clin Psychiatry. 2008. PMID: 18312042 Clinical Trial.